SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001078782-13-001653
Filing Date
2013-08-16
Accepted
2013-08-16 17:07:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f13d081613_sc13d.htm SC 13D 15418
  Complete submission text file 0001078782-13-001653.txt   16891
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83793 | Film No.: 131046081
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Filed by) CIK: 0001542484 (see all company filings)

Type: SC 13D